共 879 条
[1]
Long GV(2017)Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma N Engl J Med 377 1813-1823
[2]
Hauschild A(2017)Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma New Engl J Med 377 1824-1835
[3]
Santinami M(2019)Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium Lancet Oncol 20 e378-e389
[4]
Atkinson V(2017)Breast-conserving surgery following neoadjuvant therapy—a systematic review on surgical outcomes Breast Cancer Res Treat 168 1-12
[5]
Mandalà M(2008)Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease J Clin Oncol 26 814-819
[6]
Chiarion-Sileni V(2004)Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania Cancer 100 2512-2532
[7]
Larkin J(1994)Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6 Eur J Cancer 30 645-652
[8]
Nyakas M(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer Trial 10902 J Clin Oncol 19 4224-4237
[9]
Dutriaux C(2001)Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 2001 96-102
[10]
Haydon A(2005)Sometimes a great notion—an assessment of neoadjuvant systemic therapy for breast cancer J Natl Cancer Inst 97 159-161